YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

In vitro Metabolism of Pentoxifylline Metabolite M-l in Human Liver Microsomes

인체 간 microsome에서 pentoxifylline 대사체 M-1의 시험관내 대사

  • 신혜순 (덕성여자대학교 약학대학)
  • Published : 1999.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

The metabolism and pharmacokinetics of M-l, which is metabolite of pentoxifylline, have been studied in human liver microsomes. Biphasic kinetics was observed from the Eadie-Hofstee plot for the formation of both metabolites of M-l. For the kinetics of pentoxifylline, mean values of $V_{max1}{\;}and{\;}V_{max2}$ were 1,648 and 5,622 nmol/min/mg protein, and the estimated values of $K_{ml}{\;}and{\;}K_{m2}$ were 0.180 and 4.829 mM, respectively. For M-3, mean values of $V_{max1}{\;}and{\;}V_{max2}$ were 0.062 and 0.491 nmol/min/mg protein, and estimated values of $K_{ml}{\;}and{\;}K_{m2}$ were 0.025 and 1.216 mM. The formations of pentoxifylline and M-3 from M-1 were indentified by using several selective inhibitors of cytochrome P450 isoformes at 0.05-5 mM concentration of M-1 in human liver microsomes. For the analysis of low (0.05 mM) concentration of M-1, where the affinity was expected as low, indicated that CYPlA2 and CYP3A4 were major P450 isoforms responsible for pentoxifylline and M-3 formation. CYP3A4 and CYP2A6 appeared to be P450 isoforms responsible for M-3 formation at high (5 mM) concentration of M-1.

Keywords

References

  1. Arzneimittelforschung v.22 Struktur der ausscheidung sprodukte des 3.7-dimethyl-1-(5-oxohexyl)-xanthines (BL 191) beim menschen Von, H. J.;Bedebem, Hinze, G.;Sode, A.
  2. Arzneimittelforschung v.39 Metabolism and pharma- cokinetics and $^{14}C$ pentoxifylline in healthy volun- teers Bryce, T. A.;Chamberlain, J.;Hillbeck, D.;Macdonald, C. M.
  3. Anal. Pharmacother. v.27 Clinical on pentoxifylline therapy for diabetes induced peripheeral vascular disease Campbell, R. K.
  4. Angiology v.45 Pentoxifylline for intermittent claudication: a critical review Ernst, E.
  5. Clinic. Infec. Dis. v.18 Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study Landman, D.;Sarai, A.;Sathe, S. S.
  6. Clin. Infect. Dis. v.18 Pentoxifylline for the treatment of infection with human immunodeficiency virus Dezube, B. J.
  7. Human Reproduc. v.9 Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administration Tournaye, H.;Van, A. C.;Steirteghem, A.;Devroey, P.
  8. Blood v.78 Phase I-II trial of pentoxifylline for the prevention of transplant related toxicities following bone marrow transplantation Bianco, J. A.;Appelbaum, F. R.;Nemunaitis, J.;Almgren, J.;Andrews, F.;Kettner, P.;Shields, A.;Singer, J. W.
  9. Cancer Res. v.54 A Feber Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine activated killer cell therapy for metastatic renal cell carcinoma Thompson, J. A.;Bianco, J. A.;Benyunes, M. C.;Neubauer, M. A.;Slattery, J. T.
  10. J. Heart and Lung Trans. v.15 Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation Carrier, M.;Pelletier, G.;White, M.;Bois, D.;Pelletier, C.
  11. Pharmaceu. Res. v.4 Pharmacokinetics of pentoxifylline during concomitant theophylline administration of Rats Rocci, M.;Luke, D.;Saccr, C.
  12. J. Exp. Med. v.181 Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice Abraham, E.;Bursten, S.;Shenkar, R.;Allbee, J.;Tuder, R.;Woodson, P.;Guidot, D. M.;Rice, G.;Singer, J. W.;Repine, J. E.
  13. Proc. Natl. Acad. Sci. v.9 Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid Rice, G. C.;Brown, P.A.;Nelson, R. J.;Bianco, J. A.;Singer, J. W.;Bursten, S.
  14. Crit. Care. Med. v.24 Lysofylline decrease white cell adhesives and improves survival after experimental hemorrhgic shock Waxman, K.;Daughters, K.;Aswani, S.
  15. Urology v.47 High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the university of chicago experience Shulman, K. L.;Stadler, W. M.;Vogelzang, N. J.
  16. Cancer Res. v.56 Lisofylline inhibits transforming growth factor release and enhances trilineage hematopoietics recovery after 5-fluorouracil treatment in mice Clarke, E.;Rice, G. C.;Weeks, R. S.;Jenkins, N.;Nelson, R.;Bianco, J. A.;Singer, J. W.
  17. Drug. Metab. Dispos. v.24 Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol Lillibridge, J. A.;Kalhorn, T. F.;Slattery, J. T.
  18. Drug. Metab. Dispos. v.25 Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes Lee, S.;Slattery, J. T.
  19. Biochem. Pharmacol. v.45 Oxidation of acetaminophen to N-acetyl-benzoquinone by human CYP3A4 Thummel, K. E.;Lee, C. A.;Kunze, K. L.;Nelson, S. D.;Slattery, J. T.
  20. Anal. Biochem. v.72 A rapid and senstive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Bradford, M. A.
  21. J. Chromatography. v.575 Determination of pentoxifylline and its metabilites in human plasma by high performance liquid chromatography with solid-phase extraction Mancinelli, A.;Pace, S.;Marzo, A.;Martelli, E. A.
  22. Drug. Metab. Dispos. v.23 Cytochrome P450 inhibitors. Evaluation of specificities in the vitro metabolism of therapeutic agents by human liver icrosomes Newton, D. J.;Wang, R. W.;Lu,, A. Y. H.
  23. J. Pharm. Exp. Ther. v.277 Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes Martine, B.;Viviane, M.;Yves, B.;Genrard, F.
  24. Cancer Res. v.57 Oxidation of cyclophosphamide to 4-hydroxycyclop-hosphamide in human liver microsomes Ren, S.;Yang, J. S.;Kalhorn, T. F.;Slattery, J. T.
  25. Clinical Pharmacol. Ther. v.58 Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo Mitra, A. K.;Tummel, K. E.;Kalhorn, T. F.;Kharasch, E. D.;Unadkat, J. D.;Slattery, J. T.
  26. Drug. Metab. Dispos. v.24 Catalytic role of cytochrome P450 2B6 in the N-demthylation of S-mephenytoin Heyn, H.;White, R. B.;Stevens, J. C.
  27. J. Pharm. Sci. v.87 CYP3A4-mediated oxidation of lisofylline tolisofylline 4,5-diol in human liver microsomes Shin, H.;Slattery, J. T.